Growth HealthTech / Life Sciences Investors in Canada

Capital catalyst for precision medicine and next-generation medical devices at point of value acceleration.

BDC's debt financing arm providing loans to Canadian businesses across all stages. Over $9.7B in annual loan acceptances across 123+ business centres serving 60,000+ clients. Products include tech com

BMO's technology and innovation banking group launched in 2019 providing venture debt and growth financing to Canadian tech companies. Expanded aggressively post-SVB to capture market share.

Canada's second-largest pension fund and one of the world's largest institutional investors. Active direct investor and LP in the Canadian VC ecosystem.

Leading Canadian mid-market PE firm investing through buyouts, growth and acquisition financings since 2002.

Venture capital firm investing in high-quality emerging life sciences companies at the pre-clinical and clinical development stage in Canada and the US.

Invest in innovative private companies developing breakthrough therapies. Join last or second-to-last private financing round.

Quebec's largest labour-sponsored venture capital fund with $20B+ in net assets. Provides venture and development capital to thousands of Quebec businesses from startup to expansion.

Toronto-based growth capital firm founded in 2008, one of Canada's largest investment firms, investing in enterprise software and internet companies with nearly $3B raised across 5 growth funds.

Largest non-bank venture debt lender globally with $10B+ portfolio. Active lender to Canadian tech and life sciences companies. Publicly traded (NYSE: HTGC). Provides venture debt from $5M-$200M+.

Non-bank venture lending company providing venture debt to VC-backed technology, life sciences, healthcare, and sustainability companies. Publicly traded (NASDAQ: HRZN). Active in the North American m

Growth-stage AI companies with proven product-market fit in Canada and UK.

Quebec provincial government's investment arm fostering economic development. Offers loans, loan guarantees, and equity investments, frequently co-investing alongside private VCs.

JPMorgan's Canadian innovation economy unit expanding aggressively with 5 dedicated tech bankers. Hired Scotiabank's former head of TIB (David Rozin) to lead Canadian expansion, picking up hundreds of

National Bank's technology banking group offering venture lending, growth and M&A financing for tech companies for over 20 years. Acquired SVB's ~C$1B Canadian loan portfolio in 2023. Also operates NA

Health tech and B2B technology at inflection point between commercialization and scale.

Innovative private equity fund supporting entrepreneurs and executives fostering innovation in Canada's health and wellness industry.

Private venture capital and mutual fund management company with 1 fund and 51 deals recorded.

Scotiabank's tech lending arm with ~C$2B lent to Canadian tech companies including BenchSci, Helcim, GeoComply, and Field Effect. Launched in 2019, expanded post-SVB collapse. Also operates via subsid

Global investment firm with $620M+ USD in AUM. Partners with visionary founders across technology and healthcare. Fund III closed at $338M CAD.

Venture banking division of Stifel providing venture debt ($1M-$50M+), treasury management, and capital raising for seed through IPO-stage tech companies. Over 100 bankers, $10B+ in loan commitments.

Non-bank venture debt and equipment financing provider for growth-stage companies backed by leading venture capital firms. Publicly traded (NASDAQ: TRIN). Active lender in the North American market in

Flexible growth capital solutions (debt, convertible debt, structured equity) to mid-later stage technology companies. $10M-$50M.

Montreal-based PE firm partnering with management teams of mid-market businesses in Quebec and Canada to drive growth.

Pioneered venture debt in 1980. $7.8B deployed across 1,400+ companies including Canadian firms. Now investing out of 11th institutional fund. Acquired by P10 in 2022. Flexible, founder-friendly lendi